Activity Dates: 04/21/2009 - 04/21/2012
This course is closed. Please look for other available products in CPNP University.
If you are a pharmacist, nurse practitioner or other healthcare professional involved in the comprehensive medication management of psychiatric and/or neurological patients, we invite you to participate in this online course.
Idiopathic dystonia and tremor disorders are movement disorders that are underrecognized or undertreated. Familiarity with the clinical features and available treatments will allow clinicians to better identify and manage patients with dystonia or tremor disorders. This session will utilize video cases as learning tools.
Idiopathic dystonia is a neurologic condition and can be focal, segmental, or generalized. However, focal cervical dystonia is more common in characterized by involuntary contractions of cervical musculature resulting and abnormal movements and postures of the head. It is often disabling and disfiguring. Although primarily a motor disorder, cervical dystonia is also characterized by derangements of sensory function. For example, pain can be present. Sensory tricks (gestes antagonistes) are interesting examples of abnormalities in sensorimotor integration. The majority of cervical dystonias are idiopathic and focal, i.e., there is no other associated clinical or neuroimaging features and they remain restricted to the neck and shoulder girdle muscles. There is no definitive diagnostic algorithm for dystonias nor is there universal agreement on the best approaches to management. Oral agents such as antimuscarinics provide modest benefit and are limited by side effects. Botulinum toxin provides significant relief and restores head and neck position. The role of various agents will be discussed.
Essential tremor is a common movement disorder of adulthood that interferes with the performance of functional and social activities. This type of tremor can be mistaken as Parkinson’s disease or dismissed as a benign condition. Additionally, patients with cervical dystonia may have coexisting signs of limb or head tremor which can make recognition between dystonic and essential tremor difficult.
Currently, the mainstays of pharmacotherapy consist of propranolol and primidone. However, various antiepileptic drugs can also be offered to provide symptomatic benefits. Thalamic deep brain stimulation is an alternative when medical therapy is inadequate. Effective therapies are available for focal dystonias and essential tremor. Thus, proper recognition and treatment are key for achieving optimal outcomes.
You will proceed through the following steps to satisfactorily complete this course:
This course is provided online at cpnp.org and consists of the speaker audio and slides. A PDF file of the slides is also provided and access is available to participants indefinitely although ACPE credit is available only through the course expiration date.
Participants in this course must complete an examination and achieve a score of 60% or greater. Successful completion of the course also requires the completion of a course evaluation. ACPE statements of credit can be retrieved by participants online at cpnp.org immediately upon successful completion of the course.
CPNP has invested in supporting the most popular web browsers and leveraging software that our members use daily. Beyond PDF downloads, the rest of the system is built on HTML5, a technology that most up-to-date browsers will support. To access CPNP course materials online, you will need:
CPNP web sites no longer fully support Microsoft Internet Explorer 9 and older or Windows Vista and older. We cannot guarantee that the site will function perfectly on every device and configuration, but using the latest version of the software above will greatly improve your experience.
Jack Chen, PharmD, BCPS, CGPView biographical information and disclosures
The College of Psychiatric and Neurologic Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This self-study course provides 1.0 contact hours (0.1 CEUs) of knowledge-based continuing education credit from CPNP approved programming. The ACPE universal program number assigned to this course is 0284-0000-09-012-H01-P (1.0 contact hours).
ACPE approved contact hours are accepted for ANCC Certification Renewal (see pages 5 and 6): At least 50% (37.5 hours) of your 75 continuing education hours must be formally approved continuing education hours. Formally approved continuing education hours meet one or more of the criteria listed below:
Off-Label Use: This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA (see faculty information and disclosures). The opinions expressed in the educational activity do not necessarily represent the views of CPNP and any educational partners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer: Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
This programming was supported in part by grants from Bristol-Myers Squibb, Forest Laboratories, Inc., Lilly, Schering-Plough, Cyberonics, Shire, and Janssen, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc. administered by Ortho-McNeil Janssen Scientific Affairs, LLC.
Supported by an educational grant from Janssen, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc. administered by Ortho-McNeil Janssen Scientific Affairs, LLC.